Researchers at the Pennington Biomedical Research Center have found new clues about how the drug tirzepatide, also known by ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

Health and wellness influencer Janelle Rohner has been using a GLP-1 medication to lose weight. “This isn't easy to say, but ...

Researchers at Karolinska Institutet in Stockholm, Sweden, have shown that specific blood biomarkers can predict development of dementia up to 10 years before symptoms appear. But their primary value ...

Health and wellness influencer Janelle Rohner had been documenting her weight loss journey long before she admitted to using a GLP-1 to help her progress. The nurse initially kickstarted her wellness ...

Defensive lineman Desmond Watson lost 26 pounds in less than a month, which left him in position to be heaviest player picked ...

GLP-1 receptor agonists are effective weight-loss medications, but they may also decrease muscle mass, raising concerns about ...

Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...

Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

We recently published a list of the 11 Most Promising Small-Cap Stocks According to Analysts. In this article, we are going ...